Galmed Pharmaceuticals Ltd.

GLMDNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
0.59 USD
↘ 0.02 (3.00%)🟢LIVE (AS OF 02:26 PM EDT)
🟢Market: OPEN
Open?$0.61
High?$0.63
Low?$0.57
Prev. Close?$0.60
Volume?50.9K
Avg. Volume?N/A
VWAP?$0.61
Bid / Ask
Bid?$0.49 × 100
Ask?$0.68 × 100
Spread?$0.19
Midpoint?$0.59
Valuation & Ratios
Market Cap?4.0M
Shares Out?6.6M
Float?6.3M
Float %?95.8%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
Themes
Biotech - Drug Development›Metabolic & CardiometabolicHealthcare - Oncology›Targeted Therapy & Precision Oncology
Employees
6
Market Cap
4.0M
Industry
N/A
Website
www.galmedpharma.com
Listed
2014-03-13
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
MarketsMoversWatchlist